Alvogen Malta Operations Ltd. – Trademark Portfolio

Entity Type: 11

Alvogen Malta Operations Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LOREEV XR. The owner is based in San Gwann.

Alvogen Malta Life Sciences Park, Bldg.1

Level 4, Sir Temi Zammit Buildings

San Gwann SGN3000 , MT

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LOREEV
LOREEV
Abandoned 2019
LOREEV XR
LOREEV XR
Registered 2019
FLOXIN
FLOXIN
Abandoned 2016
LOREEV
LOREEV
Abandoned 2016

Trademark Classifications

Alvogen Malta Operations Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Alvogen Malta Operations Ltd. have?

Alvogen Malta Operations Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.

What trademark classes does Alvogen Malta Operations Ltd. file in?

Alvogen Malta Operations Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Alvogen Malta Operations Ltd.'s most well-known trademarks?

Alvogen Malta Operations Ltd.'s registered trademark portfolio includes well-known marks such as LOREEV XR. These are among 1 currently registered trademark in the portfolio.

What is Alvogen Malta Operations Ltd.'s trademark registration success rate?

Alvogen Malta Operations Ltd. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.